AbbVie said Friday it has officially asked the Food and Drug Administration to approve a treatment meant to keep symptoms of Parkinson’s disease in check for longer than currently available therapies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,